Tumor volumes as a predictor of response to the anti-EGFR antibody drug conjugate depatuxizumab mafadotin.
Gan HK, Parakh S, Lassman AB, Seow A, Lau E, Lee ST, Ameratunga M, Perchyonok Y, Cao D, Burvenich IJG, O'Keefe GJ, Rigopoulos A, Gomez E, Maag D, Scott AM.
Gan HK, et al. Among authors: seow a.
Neurooncol Adv. 2021 Aug 3;3(1):vdab102. doi: 10.1093/noajnl/vdab102. eCollection 2021 Jan-Dec.
Neurooncol Adv. 2021.
PMID: 34549181
Free PMC article.